Bio-Rad Laboratories Class A
244 hedge funds and large institutions have $2.54B invested in Bio-Rad Laboratories Class A in 2015 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 86 reducing their positions, and 16 closing their positions.
326% more call options, than puts
Call options by funds: $1.54M | Put options by funds: $363K
131% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 16
8% more funds holding
Funds holding: 225 → 244 (+19)
0.64% more ownership
Funds ownership: 78.13% → 78.77% (+0.64%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 86
10% less capital invested
Capital invested by funds: $2.83B → $2.54B (-$287M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$39.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$36.7M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$36.2M |
| 4 |
Millennium Management
New York
|
+$26M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$21.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
CIBC World Markets
New York
|
-$45.2M |
| 2 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$22.6M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$18.5M |
| 4 |
AI
Ariel Investments
Chicago,
Illinois
|
-$17.7M |
| 5 |
Two Sigma Investments
New York
|
-$11.7M |
BIO Hedge Fund Activity: Q3 2015 in Review
244 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2015, worth a combined $2.54B — down 10% from $2.83B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new BIO positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 86 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $39.8M. The largest seller was CIBC World Markets, exiting entirely with an estimated $45.2M sold.
- 244 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2015, up from 225 in Q2 2015.
- Funds reported $2.54B of Bio-Rad Laboratories Class A stock for Q3 2015, down 10% quarter-over-quarter.
- 37 funds opened new Bio-Rad Laboratories Class A positions in Q3 2015 and 16 closed out, a net change of +21 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2015 was BNP Paribas Financial Markets, an estimated $39.8M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2015 was CIBC World Markets, an estimated $45.2M sold.
Based on aggregated 13F filings for Q3 2015.